Cellular and Tissue Models
Integrated in vitro, tissue-engineered, and ex vivo testing provides mechanistic and performance-data to support product optimization, risk assessment, regulatory submissions, and successful clinical translation. iFyber evaluates biocompatibility, biological response, functional performance, and safety across diverse biomaterials, medical devices, and investigational therapeutics to help teams advance safe, effective products efficiently from early development through preclinical evaluation.
In Vitro Biocompatibility Testing
In vitro biocompatibility testing evaluates how biomaterials, medical devices, and investigational compounds interact with mammalian cells under controlled laboratory conditions. These studies help researchers assess cytotoxicity, metabolic activity, proliferation, membrane integrity, morphology, and biological responses that inform material selection, product optimization, and regulatory decision‑making.
iFyber's Capabilities in In Vitro Testing
iFyber designs biocompatibility studies around the intended use of each technology, tailoring assay formats to support ISO 10993 compliance, product development needs, and regulatory submissions. Our team also investigates unexpected or failed biocompatibility results, identifies potential causes, and develops follow‑up studies to resolve technical challenges efficiently.
Capabilities Include:
- In vitro biocompatibility screening
- Customized assay design
- Investigation of failed biocompatibility results
- Biological response characterization
- Support for ISO 10993 and regulatory submissions
- Collaborative troubleshooting and study refinement
The MTT assay provides a quantitative assessment of cellular metabolic activity as an indicator of cell viability. The MTT assay has been demonstrated to be a relevant predictor of in vivo biocompatibility performance, highlighting its usefulness as a screening assay for new biomaterials or investigational compounds.
The Alamar Blue assay provides a quantitative assessment of cellular metabolic activity as an indicator of cell viability. Its non-destructive nature makes it particularly useful for monitoring cellular responses to biomaterials or investigational compounds while preserving cells for subsequent analyses. This approach provides a sensitive and reliable method for evaluating cytocompatibility and can complement other viability assays in the characterization of cellular responses.
The LIVE/DEAD staining provides a complementary assessment of cell viability by simultaneously evaluating intracellular activity and plasma-membrane integrity. - This multiparametric approach is useful for characterizing cellular responses and for guiding subsequent mechanistic testing.
Other available in vitro services include TUNEL Assay, BRDU Assay, Bright Field Microscopy, Neutral Red Uptake, Trypan Blue Exclusion, Bacterial Reverse Mutation Assay, Platelet activation, Hemolysis assay. Assays are selected and configured according to the test article, biological question, and applicable study requirements.
Tissue-engineered and Ex Vivo Models
Tissue-engineered and ex vivo models bridge the gap between cell-based assays and more complex preclinical studies by preserving key aspects of tissue architecture, extracellular matrix, and multicellular interactions. These models help researchers assess efficacy, troubleshoot unexpected safety results, and understand product behavior across escalating biological complexity.
iFyber's Capabilities in Tissue Modeling
iFyber evaluates device and therapeutic interactions across tissue‑engineered and ex vivo systems, supporting both efficacy and safety assessments. Our team troubleshoots failed biocompatibility results, designs follow‑up studies and develops model systems ranging from monolayer cultures to human viable skin to address specific development needs.
Capabilities Include:
- 3D cell and tissue model development
- Cell–biomaterial interaction studies (stem cells, immune cells, osteoblasts, endothelial cells, PBMCs, M1/M2 polarization)
- Human viable skin models for wound healing, infection, and cytokine/growth factor analysis
- Mammalian–microbial and cell–virus co‑culture systems
- Decellularization and demineralization workflows
- Recellularization assays for cell infiltration and biomaterial degradation
- ISO‑aligned biocompatibility and safety testing
- Skin irritation testing using 3D tissue models
- Endotoxin and pyrogenicity assays
Mechanistic and Functional Response Analysis
Mechanistic and functional response analysis and integrates physical, chemical, mechanical, and biological measurements to characterize biomaterials and tissue‑engineered systems under application-relevant conditions. These studies help researchers understand durability, degradation, mechanical behavior, and functional performance relevant to clinical use.
iFyber's Capabilities in Mechanistic and Functional Response Analysis
iFyber characterizes material properties, evaluates changes over time, and assesses functional performance using physical, chemical, and biological testing approaches. These studies support product development, performance validation, and regulatory activities.
Capabilities Include:
- Comprehensive physical characterization
- Thermal analysis and decomposition profiling
- Surface area and particle size evaluation
- Porosity and interconnectivity assessment
- Mechanical property testing
- Molecular weight analysis
- Pre‑/post‑study material comparison
- Sterilization impact assessment
Beyond Standard CRO Testing
A Trusted, Global-Serving Contract Research Organization
Engage with iFyber’s Scientific Team
Connect with iFyber to explore how cellular and tissue models can support your product development.